Abiopharma

51Talk Online Education Group Announces First Quarter 2026 Results

Fervo Energy to Report First Quarter 2026 Results on June 22, 2026

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

Announcement of EGM Results

PENN Entertainment Celebrates the Official Opening of New Hotel at Hollywood Casino Columbus

Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting

QXO Announces Early Tender Results of Cash Tender Offers and Consent Solicitations for Any and All of TopBuild Corp.’s 4.125% Senior Notes due 2032 and 5.625% Senior Notes due 2034 and Receipt of Requisite Consents

Roots Reports First Quarter Fiscal 2026 Results & Business Update

Mandatory Cash Dividend/ Distribution: